ARTICLE
This journal isThree tailored ansa-type Zr (IV)-and Hf (IV)-complexes, Zr-1, Hf-1 and Zr-2, all bridged by a dimethylsilylene group and bearing both a 6-[2-(BR2)phenyl]pyrid-2-yl motif (R = ethyl, mesityl) and an η 1 /η 5 -bound ligand with different Lewis base character and steric demand, have been synthesized. Their structures have been determined by single-crystal X-ray diffraction analysis. Upon activation with methylalumoxane (MAO), Zr-1, Hf-1 and Zr-2 are capable of polymerizing norborn-2-ene (NBE) via ring-opening metathesis polymerization (ROMP). In the MAO-activated copolymerization of ethylene (E) with NBE; however, pure vinyl insertion polymerization (VIP)-derived poly(NBE)-co-poly(E) is obtained by Zr-1, Hf-1 and the model pre-catalyst (Zr-3), which does not contain the borylamino motif. In contrast, Zr-2 yields copolymers containing both ROMP-and VIP-derived poly(NBE) ROMP -copoly(NBE) VIP -co-poly(E) units via an α-H elimination process. Variable-temperature 11 B NMR measurements allow for identifying tri-and tetracoordinated borane species. The propensity of catalysts Zr-1, Hf-1, Zr-2 and Zr-3 to switch from VIP to ROMP is discussed on the basis of their structural differences. A detailed NMR study of the reaction of Zr-1, Zr-2, Hf-1 and in particular of dimethylsilylene-bis(6-[2-(diethylboryl)phenyl]pyrid-2-ylamido)ZrCl 2 (Zr-4) with MAO and with MAO/NBE clarifies the reaction cascade from VIP to ROMP and allows for establishing a general concept for a tailored switch from VIP to ROMP within the same polymer chain, allowing for tandem VIP -ROMP copolymerization of E with NBE.
ARTICLEThis journal is
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.